Clinical Trial Update: Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update evaluates bortezomib in patients with metastatic or recurrent colorectal cancer, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED